8 November 2017 EMA/846273/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: fluticasone propionate

Procedure no.: PSUSA/00001454/201702

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number FLUSPIRAL 125 mcg Sospensione pressurizzata per inalazione FLUSPIRAL 50 mcg Sospensione pressurizzata per inalazione FLUSPIRAL 100 mcg Polvere per inalazione

not available

028675179

A. MENARINI - INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.

IT

not available

028675104

A. MENARINI - INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.

IT

not available

028675268

IT

FLUSPIRAL 250 mcg Polvere per inalazione

not available

028675270

FLUSPIRAL 250 mcg Sospensione pressurizzata per inalazione Fluspiral 500 mcg Polvere per inalazione

not available

028675181

A. MENARINI - INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. A. MENARINI - INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. A. MENARINI - INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.

not available

028675282

IT

FLUSPIRAL 500 mcg/2 ml Sospensione da nebulizzare ФЛИКСОТИД 50 ИНХАЛЕР 50 микрограма/впръскване , суспензия под налягане за инхалация ФЛИКСОТИД 250 ИНХАЛЕР 250 микрограма/впръскване , суспензия под налягане за инхалация Truflo 125 micrograme suspensie de inhalat presurizată

not available

028675294

not available

20020594

A. MENARINI - INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. A. MENARINI - INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. SOPHARMA AD

not available

20020592

SOPHARMA AD

BG

IE/H/0434/001

7864/2015/01

CIPLA (EU) LIMITED

RO

List of nationally authorised medicinal products EMA/846273/2017

IT IT

IT BG

Page 2/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Truflo 250 micrograme suspensie de inhalat presurizata Truflo 125 mikrograma/dozi, stlaceni inhalat, suspenzija Truflo 250 mikrograma/dozi, stlaceni inhalat, suspenzija Arquist 125 mikrogramov v jednej dávke inhalačnej suspenzie v tlakovom obale Arquist 250 mikrogramov v jednej dávke inhalačnej suspenzie v tlakovom obale Труфло 125 микрограма на впръскване, суспензия под налягане за инхалация Труфло 250 микрограма на впръскване, суспензия под налягане за инхалация Truflo125 microgram per actuation pressurised inhalation, suspension Truflo250 microgram per actuation pressurised inhalation, suspension Prutica, 0,5 mg/g kräm Sonera 0,5 mg/g krem

IE/H/0434/002

7865/2015/01

CIPLA (EU) LIMITED

RO

IE/H/0434/001

HR-H-396395512

CIPLA (EU) LIMITED

HR

IE/H/0434/002

HR-H-620322804

CIPLA (EU) LIMITED

HR

IE/H/0434/001

14/0184/15-S

S&D PHARMA CZ, SPOL. S R.O.

SK

IE/H/0434/002

14/0185/15-S

S&D PHARMA CZ, SPOL. S R.O.

SK

IE/H/0434/001

20150321

S&D PHARMA CZ, SPOL. S R.O.

BG

IE/H/0434/001

20150322

S&D PHARMA CZ, SPOL. S R.O.

BG

IE/H/0434/001

PA 1809/025/001

CIPLA (EU) LIMITED

IE

IE/H/0434/002

PA 1809/025/002

CIPLA (EU) LIMITED

IE

NL/H/3524/001 NL/H/3524/001/DC

53053 15-10736

EXELTIS HEALTHCARE S.L EXELTIS HEALTHCARE S.L

SE NO

List of nationally authorised medicinal products EMA/846273/2017

Page 3/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Prutica Casoflune 0,5 mg/g krém Nasofan Nosní sprej, suspenze Nasofan Aqueous 50 microgram Nasal Spray Suspension Fluticasona Teva 50 microgramos suspensión para pulverización nasal Fanipos, 50 μg/dawkę donosową, aerozol do nosa, zawiesina Nasofan 50 mikrog/annos nenäsumute, suspensio Nasofan Aqueous 50 microgram Nasal Spray

NL/H/3524/001/DC NL/H/3524/001

29825 46/654/15-C

EXELTIS HEALTHCARE S.L EXELTIS CZECH S.R.O.

DK CZ

UK/H/0810/001

24/525/05-C

CZ

UK/H/0810/001

PA 0282/090/001

UK-H-0810-001

67852

TEVA CZECH INDUSTRIES S.R.O NORTON HEALTHCARE LTD T/A IVAX PHARMACEUTICALS UK TEVA PHARMA S.L.U

UK/H/0810/001

12061

TEVA PHARMACEUTICALS POLSKA SP. Z O.O.

PL

UK/H/0810/001

21425

TEVA SWEDEN AB

FI

UK/H/0810/001

PL 00530/0745

UK

Nasofan 50 mikrogramová nosová suspenzná aerodisperzia Flutica-Teva® 50 Mikrogramm Nasenspray, Suspension|Wirkstoff: Fluticason-17-propionat Nasofan 50 míkróg/skammt nefúði Flutirin szuszpenziós orrspray

UK/H/0810/001

24/0417/05-S

NORTON HEALTHCARE LTD T/A IVAX PHARMACEUTICALS UK TEVA CZECH INDUSTRIES S.R.O

UK/H/0810/001

66605.00.00

TEVA GMBH

DE

UK/H/0810/001

IS/1/13/088/01

TEVA SWEDEN AB

IS

UK/H/0810/001

OGYI-T-20311/01

TEVA GYÓGYSZERGYÁR ZRT

HU

List of nationally authorised medicinal products EMA/846273/2017

IE ES

SK

Page 4/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Fluticansonpropionat ”Teva” 50 mikrogram/dosis, næsespray, suspension Fluticasona Nasofan 50 microgramas Suspensão para pulverização nasal. Fluticasona Nasofan 50 microgramas Suspensão para pulverização nasal. Nasofan Aqueous 50 microgram Nasal Spray Suspension Nasofan 50 microgrammi spray nasale sospensione. Nasofan 50 microgrammi spray nasale sospensione. Nasofan 50 microgrammi spray nasale sospensione. Flonase, næsespray, suspension

UK/H/0810/001

38268

TEVA DENMARK A/S

DK

UK/H/0810/001

5010616

TEVA PHARMA – PRODUTOS FARMACÊUTICOS LDA

PT

UK/H/0810/001

5010608

TEVA PHARMA – PRODUTOS FARMACÊUTICOS LDA

PT

UK/H/0810/001

MA1139/00101

MT

UK/H/0810/001

037038015/M

NORTON HEALTHCARE LTD T/A IVAX PHARMACEUTICALS UK TEVA ITALIA S.R.L.

UK/H/0810/001

037038027/M

TEVA ITALIA S.R.L.

IT

UK/H/0810/001

037038039/M

TEVA ITALIA S.R.L.

IT

UK/H/5780/001

54029

DK

Flixonase Allergy 50 micrograms/actuation nasal spray, suspension Flonase 50 micrograme/doza spray nazal suspensie Flixonase Allergia 50 mikrogramm/adag szuszpenziós orrspray

UK/H/5780/001

MA575/00901

GLAXOSMITHKLINE CONSUMER HEALTHCARE A/S GLAXOSMITHKLINE EXPORT LTD

UK/H/5780/001

7856/2015/01

RO

UK/H/5780/001

OGYI-T-22848/01

GLAXOSMITHKLINE CONSUMER HEALTHCARE S.R.L. GLAXOSMITHKLINECONSUMER KFT.

List of nationally authorised medicinal products EMA/846273/2017

IT

MT

HU

Page 5/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH & CO. KG GLAXOSMITHKLINE CONSUMER HEALTHCARE A/S GLAXOSMITHKLINE CONSUMER HEALTHCARE A/S

DE

GLAXOSMITHKLINE CONSUMER HEALTHCARE, PRODUTOS PARA A SAÚDE E HIGIENE, LDA GLAXOSMITHKLINE CONSUMER HEALTHCARE CZECH REPUBLIC S.R.O. GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED GLAXOSMITHKLINE CONSUMER HEALTHCARE (IRELAND) LTD GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED

PT

GLAXOSMITHKLINE CONSUMER HEALTHCARE CZECH REPUBLIC S.R.O. GLAXOSMITHKLINE CONSUMER HEALTHCARE S.P.A.

CZ

number Flixonase 50 Mikrogramm / Sprühstoß Nasenspray, Suspension Flutide 50 mikrogrammaa/annos nenäsumute, suspensio Flutide 50 mikrogram/dos nässpray, suspension flutikasonpropionat Flonaze 50 microgramas/dose suspensão para pulverização nasal Flutikazónpropionát GSK 50 mikrogramov Nosová suspenzná aerodisperzia Flixonase, 50 mikrogrammi/pihustuses ninasprei, suspensioon Fluticasone propionate 50 micrograms/actuation nasal spray, suspension Flixonase 50 mikrogrami/ izsmidzinājumā deguna aerosols, suspensija Flixonase 50 mikrogramů/dávka nosní sprej, suspenze Fluticasone GSK Consumer Healthcare 50 microgrammi/erogazione spray nasale, sospensione

UK/H/5780/001

92297.00.00

UK/H/5780/001

32208

UK/H/5780/001

32208

UK/H/5780/001

5658323

UK/H/5780/001

69/0336/15-S

UK/H/5780/001

878315

UK/H/5780/001

PA 678/118/1

UK/H/5780/001

15-0221

UK/H/5780/001

24/444/15-C

UK/H/5780/001

043645011

List of nationally authorised medicinal products EMA/846273/2017

FI FI

SK EE IE LV

IT

Page 6/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixonase 50 mikrogramų/išpurškime nosies purškalas (suspensija) Flixonase GSK ConsHealth 50 microgram/dosis, neusspray suspensie Flonase Allergy, 50 mikrogramów/dawkę, aerozol do nosa, zawiesina Flutikazonpropionat GSK 50 mikrogramov/vpih pršilo za nos, suspenzija Flixotide Allergy 50 μικρογραμμάρια/ψεκασμ ό ρινικό εκνέφωμα, εναιώρημα Flonase 50 microgramos/pulverizaci ón, suspensión para pulverización nasal Fluticasone propionate 50 micrograms/actuation nasal spray, suspension Flunase Aqueous 50 microgram Nasal Spray

UK/H/5780/001

LT/1/15/3806/001

GLAXOSMITHKLINE EXPORT LTD

LT

UK/H/5780/001

RVG 115221

GLAXOSMITHKLINE CONSUMER HEALTHCARE B.V

NL

UK/H/5780/001

22862

GLAXOSMITHKLINE CONSUMER HEALTHCARE SP. Z O.O.

PL

UK/H/5780/001

H/16/02160/001

GLAXOSMITHKLINE D.O.O.

SI

UK/H/5780/001

3074501

GLAXOSMITHKLINE AEBE

GR

UK/H/5780/001

79947

GLAXOSMITHKLINE CONSUMER HEALTHCARE, S.A.

ES

UK/H/5780/001

PL 44673/0102

UK

UK/H/0920/001

PL 00530/0761

Floebb Inhaler 50 micrograms per actuation pressurised inhalation, suspension

UK/H/5824/001

PL 04569/1490

GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED NORTON HEALTHCARE LTD T/A IVAX PHARMACEUTICALS UK GENERICS [UK] LIMITED

List of nationally authorised medicinal products EMA/846273/2017

UK UK

Page 7/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Floebb Inhaler 125 micrograms per actuation pressurised inhalation, suspension Floebb Inhaler 250 micrograms per actuation pressurised inhalation, suspension Floebb Inhaler 50 micrograms per actuation pressurised inhalation, suspension Floebb Inhaler 125 micrograms per actuation pressurised inhalation, suspension Floebb Inhaler 250 micrograms per actuation pressurised inhalation, suspension Brisovent Inalador 50 microgramas/dose Suspensão pressurizada para inalação Brisovent Inalador 125 microgramas/dose Suspensão pressurizada para inalação Brisovent Inalador 250 microgramas/dose Suspensão pressurizada para inalação

UK/H/5824/002

PL 04569/1491

GENERICS [UK] LIMITED

UK

UK/H/5824/003

PL 04569/1492

GENERICS [UK] LIMITED

UK

UK/H/5824/001

51550

GENERICS [UK] LIMITED

SE

UK/H/5824/002

51551

GENERICS [UK] LIMITED

SE

UK/H/5824/003

51552

GENERICS [UK] LIMITED

SE

not available

2271880

BIAL - PORTELA & Cª , SA

PT

not available

2271989

BIAL - PORTELA & Cª , SA

PT

not available

2272185

BIAL - PORTELA & Cª , SA

PT

List of nationally authorised medicinal products EMA/846273/2017

Page 8/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Brisovent Inalador 125 microgramas/dose Suspensão pressurizada para inalação Brisovent Inalador 250 microgramas/dose Suspensão pressurizada para inalação Brisovent Diskus 50 microgramas/dose Pó para inalação Brisovent Diskus 100 microgramas/dose Pó para inalação Brisovent Diskus 250 microgramas/dose Pó para inalação Brisovent Diskus 500 microgramas/dose Pó para inalação Fluticason Cipla 125 Mikrogramm/Sprühstoß Druckgasinhalation, Suspension Fluticason Cipla 250 Mikrogramm/Sprühstoß Druckgasinhalation, Suspension Fluticasona Cipla 125 microgramos/inhalación suspensión para inhalación en envase a presión

not available

2272086

BIAL - PORTELA & Cª , SA

PT

not available

2272284

BIAL - PORTELA & Cª , SA

PT

not available

2624286

BIAL - PORTELA & Cª , SA

PT

not available

2624484

BIAL - PORTELA & Cª , SA

PT

not available

2624682

BIAL - PORTELA & Cª , SA

PT

not available

2624880

BIAL - PORTELA & Cª , SA

PT

SE/H/1367/001

91141.00.00

CIPLA EUROPE NV

DE

SE/H/1367/002

91142.00.00

CIPLA EUROPE NV

DE

SE/H/1367/001

79477

CIPLA EUROPE NV

ES

List of nationally authorised medicinal products EMA/846273/2017

Page 9/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Fluticasone Cipla 250 microgram per actuation pressurised inhalation, suspension Flutikason Cipla 125 mikrogram/dose inhalasjonsaerosol, suspensjon Flutikason Cipla 250 mikrogram/dose inhalasjonsaerosol, suspensjon Flutikasoni Cipla 125 mikrog/annos inhalaatiosumute, suspensio Flutikasoni Cipla 250 mikrog/annos inhalaatiosumute, suspensio Fluticasone Cipla 125 microgrammi per erogazione, sospensione pressurizzata per inalazione Fluticasone Cipla 250 microgrammi per erogazione, sospensione pressurizzata per inalazione Flutikazon Cipla 125 mikrogramm / adag túlnyomásos inhalációs szuszpenzió

SE/H/1367/001

79478

CIPLA EUROPE NV

ES

SE/H/1367/001

13-9819

CIPLA EUROPE NV

NO

SE/H/1367/002

13-9820

CIPLA EUROPE NV

NO

SE/H/1367/001

31846

CIPLA EUROPE NV

FI

SE/H/1367/002

31847

CIPLA EUROPE NV

FI

SE/H/1367/001

043082015

CIPLA EUROPE NV

IT

SE/H/1367/002

043082027

CIPLA EUROPE NV

IT

SE/H/1367/001

OGYI-T-22740/01

CIPLA EUROPE NV

HU

List of nationally authorised medicinal products EMA/846273/2017

Page 10/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flutikazon Cipla 250 mikrogramm / adag túlnyomásos inhalációs szuszpenzió Truflo 125 mikrogram/dos inhalationsspray, suspension Truflo 250 mikrogram/dos inhalationsspray, suspension Flutikasoni Cipla 125 mikrogram/dos inhalationsspray, suspension Flutikasoni Cipla 250 mikrogram/dos inhalationsspray, suspension Flixotide Dysk, 250 mg/dawkę inhalacyjną, proszek do inhalacji Flixotide 50 microgramos, suspensión para inhalación en envase a presión Flixotide 125 microgramos, suspensión para inhalación en envase a presión Flixotide 250 microgramos, suspensión para inhalación en envase a presión

SE/H/1367/002

OGYI-T-22740/02

CIPLA EUROPE NV

HU

SE/H/1367/001

50174

CIPLA EUROPE NV

SE

SE/H/1367/002

50175

CIPLA EUROPE NV

SE

SE/H/1367/001

31846

CIPLA EUROPE NV

FI

SE/H/1367/002

31847

CIPLA EUROPE NV

FI

not available

4847

GLAXOSMITHKLINE EXPORT LTD

PL

not available

60.477

GLAXOSMITHKLINE, S.A.

ES

not available

60.478

GLAXOSMITHKLINE, S.A.

ES

not available

60.479

GLAXOSMITHKLINE, S.A.

ES

List of nationally authorised medicinal products EMA/846273/2017

Page 11/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixotide Accuhaler 100 microgramos, polvo para inhalación Flixotide Accuhaler 250 microgramos, polvo para inhalación Flixotide Accuhaler 500 microgramos, polvo para inhalación Flusonal® Accuhaler® 100 microgramos, polvo para inhalación Flusonal® Accuhaler® 500 microgramos, polvo para inhalación Flusonal® 50 microgramos, suspensión para inhalación en envase a presión Flusonal® 250 microgramos, suspensión para inhalación en envase a presión Flixonase kapi za nos 400 mikrograma (1 mg/ml), kapi za nos, suspenzija FLIXONASE sprej za nos, suspenzija Trialona 50 microgramos, suspensión para inhalación en envase a presión

not available

60.480

GLAXOSMITHKLINE, S.A.

ES

not available

60.481

GLAXOSMITHKLINE, S.A.

ES

not available

60.482

GLAXOSMITHKLINE, S.A.

ES

not available

60.528

GLAXO S.A.

ES

not available

60.530

GLAXO S.A.

ES

not available

60.525

GLAXO S.A.

ES

not available

60.527

GLAXO S.A.

ES

not available

UP/I-530-09/11-01/60

GLAXOSMITHKLINE D.O.O.

HR

not available

HR-H-653844542

GLAXOSMITHKLINE D.O.O.

HR

not available

61.787

SMITHKLINE BEECHAM FARMA, S.A.

ES

List of nationally authorised medicinal products EMA/846273/2017

Page 12/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Trialona 250 microgramos, suspensión para inhalación en envase a presión Trialona Accuhaler 100 microgramos, polvo para inhalación Trialona Accuhaler 500 microgramos, polvo para inhalación Fluticasonpropionaat Inhalator GSK 50 microgram/dosis, aërosol, suspensie Fluticasonpropionaat Inhalator GSK 125 microgram/dosis, aërosol, suspensie Fluticasonpropionaat Inhalator GSK 250 microgram/dosis, aërosol, suspensie Flixotide 0,5 mg/dos suspension för nebulisator i endosbehållare Flixotide 2 mg/dos suspension för nebulisator i endosbehållare Flixonase 400 mikrog (1mg/ml), nenätipat, suspensio

not available

61.788

SMITHKLINE BEECHAM FARMA, S.A.

ES

not available

61.971

SMITHKLINE BEECHAM FARMA, S.A.

ES

not available

61.972

SMITHKLINE BEECHAM FARMA, S.A.

ES

not available

RVG 103175

GLAXOSMITHKLINE BV

NL

not available

RVG 103168

GLAXOSMITHKLINE BV

NL

not available

RVG 103122

GLAXOSMITHKLINE BV

NL

not available

14938

GLAXOSMITHKLINE OY

FI

not available

14939

GLAXOSMITHKLINE OY

FI

DK/H/0142/001

13796

GLAXOSMITHKLINE OY

FI

List of nationally authorised medicinal products EMA/846273/2017

Page 13/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixotide Evohaler 125 mikrog/dos inhalationsspray, suspension Flixotide Evohaler 250 mikrog/dos inhalationsspray, suspension Flixotide Evohaler 50 mikrog/dos inhalationsspray, suspension Flixotide Diskus 100 mikrog/dos inhalationspulver, avdelad dos Flixotide Diskus 250 mikrog/dos inhalationspulver, avdelad dos Flixotide Diskus 500 mikrog/dos inhalationspulver, avdelad dos CUTIVATE 0,005 % Salbe CUTIVATE 0,05 % Creme

not available

13592

GLAXOSMITHKLINE OY

FI

not available

13594

GLAXOSMITHKLINE OY

FI

not available

13859

GLAXOSMITHKLINE OY

FI

not available

11902

GLAXOSMITHKLINE OY

FI

not available

11903

GLAXOSMITHKLINE OY

FI

not available

11904

GLAXOSMITHKLINE OY

FI

not available

BE171927

BE

not available

BE171936

FLIXONASE AQUA 50 Mikrogramm/Dosis Nasenspray, Suspension Flixotide 50 Mikrogramm/Dosis – Druckgasinhalation, Suspension

not available

BE181517

GLAXOSMITHKLINE PHARMACEUTICALS SA GLAXOSMITHKLINE PHARMACEUTICALS SA GLAXOSMITHKLINE PHARMACEUTICALS SA

not available

BE164446

GLAXOSMITHKLINE PHARMACEUTICALS SA

BE

List of nationally authorised medicinal products EMA/846273/2017

BE BE

Page 14/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixotide 250 Mikrogramm/Dosis – Druckgasinhalation, Suspension Flixotide Diskus 100 Mikrogramm/Dosis Einzeldosiertes Pulver zur Inhalation Flixotide Diskus 250 microgram/dosis Inhalatiepoeder, voorverdeeld Flixotide Diskus 500 microgram/dosis Inhalatiepoeder, voorverdeeld Flixotide-Nebules 2 mg/2 ml - Vernevelsuspensie Flixotide-Nebules 0,5 mg/2 ml Vernevelsuspensie Asmo-Lavi 250 microgramas/dose Suspensão pressurizada para inalação Asmo-Lavi 125 microgramas/dose Suspensão pressurizada para inalação Asmo-Lavi 50 microgramas/dose Suspensão pressurizada para inalação CUTIVATE 0,05 % Creme

not available

BE164464

GLAXOSMITHKLINE PHARMACEUTICALS SA

BE

not available

BE198746

GLAXOSMITHKLINE PHARMACEUTICALS SA

BE

not available

BE198755

GLAXOSMITHKLINE PHARMACEUTICALS SA

BE

not available

BE198764

GLAXOSMITHKLINE PHARMACEUTICALS SA

BE

not available

BE203542

BE

not available

BE203551

GLAXOSMITHKLINE PHARMACEUTICALS SA GLAXOSMITHKLINE PHARMACEUTICALS SA

not available

2283885

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

not available

2283786

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

not available

2283588

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

not available

260/10 01 0639

GLAXOSMITHKLINE PHARMACEUTICALS SA

LU

List of nationally authorised medicinal products EMA/846273/2017

BE

Page 15/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXOSMITHKLINE PHARMACEUTICALS SA GLAXOSMITHKLINE PHARMACEUTICALS SA

LU

number CUTIVATE 0,005 % Salbe FLIXONASE AQUA, 50 microgram/dosisneusspray, suspensie Flixotide 50 Mikrogramm/Dosis – Druckgasinhalation, Suspension Ubizol 0,5 mg/g Creme

not available

260/10 01 0640

not available

0260/09/08/0497

not available

2007 09 9439

GLAXOSMITHKLINE PHARMACEUTICALS SA

LU

not available

2255784

PT

Eustidil 50 microgramas/dose suspensão para pulverização nasal Asmatil 50 microgramas /dose Suspensão pressurizada para inalação Asmatil 125 microgramas /dose Suspensão pressurizada para inalação Asmatil 125 microgramas /dose Suspensão pressurizada para inalação Asmatil 250 microgramas /dose Suspensão pressurizada para inalação

not available

2285187

GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA

not available

2313880

GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA

PT

not available

2313989

GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA

PT

not available

2314086

GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA

PT

not available

2314185

GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA

PT

List of nationally authorised medicinal products EMA/846273/2017

LU

PT

Page 16/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Asmatil 250 microgramas /dose Suspensão pressurizada para inalação Flixotide 125 Inhaler CFC-Free, suspensie de inhalat presurizata Flixotide 250 Inhaler CFC-Free, suspensie de inhalat presurizata Asmo-Lavi Diskus 50 microgramas/dose pó para inalação Asmo-Lavi Diskus 100 microgramas/dose pó para inalação Asmo-Lavi Diskus 250 microgramas/dose pó para inalação Asmo-Lavi Diskus 500 microgramas/dose pó para inalação Asmatil Diskus 50 microgramas /dose Pó para inalação Asmatil Diskus 50 microgramas /dose Pó para inalação Asmatil Diskus 100 microgramas /dose Pó para inalação Asmatil Diskus 100 microgramas /dose Pó para inalação

not available

2314284

GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA

PT

not available

623/2008/01

GLAXO WELLCOME UK LIMITED

RO

not available

624/2008/02

GLAXO WELLCOME UK LIMITED

RO

not available

2623486

PT

not available

2623684

not available

2623882

not available

2624088

not available

2622587

not available

2622686

not available

2622785

not available

2622884

GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA

List of nationally authorised medicinal products EMA/846273/2017

PT PT PT PT PT PT PT

Page 17/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised PT

number Asmatil Diskus 250 microgramas /dose Pó para inalação Asmatil Diskus 250 microgramas /dose Pó para inalação Asmatil Diskus 500 microgramas /dose Pó para inalação FLIXONASE ARI 50 mikrogramov/vpih pršilo za nos, suspenzija FLIXOTIDE® 50 mikrogramov/vpih inhalacijska suspenzija pod tlakom FLIXOTIDE® 125 mikrogramov/vpih inhalacijska suspenzija pod tlakom FLIXOTIDE® 250 mikrogramov/vpih inhalacijska suspenzija pod tlakom FLIXOTIDE DISKUS 50 mikrogramov/odmerek prašek za inhaliranje, odmerjeni FLIXOTIDE DISKUS 100 mikrogramov/odmerek prašek za inhaliranje, odmerjeni

not available

2622983

not available

2623080

not available

2623288

not available

H/94/00620/004

GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE PRODUTOS FARMACEUTICOS, LIMITADA GLAXOSMITHKLINE D.O.O.

not available

H/93/00621/001

GLAXOSMITHKLINE D.O.O.

SI

not available

H/93/00621/002

GLAXOSMITHKLINE D.O.O.

SI

not available

H/93/00621/003

GLAXOSMITHKLINE D.O.O.

SI

not available

H/93/00621/004

GLAXOSMITHKLINE D.O.O.

SI

not available

H/93/00621/005

GLAXOSMITHKLINE D.O.O.

SI

List of nationally authorised medicinal products EMA/846273/2017

PT PT SI

Page 18/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number FLIXOTIDE DISKUS 250 mikrogramov/odmerek prašek za inhaliranje, odmerjeni FLIXOTIDE DISKUS 500 mikrogramov/odmerek prašek za inhaliranje, odmerjeni FLIXONASE 50 mikrogramov/vpih pršilo za nos, suspenzija FLIXONASE® 400 mikrogramov/0,4 ml kapljice za nos, suspenzija Flonase, næsespray, suspension

not available

H/93/00621/006

GLAXOSMITHKLINE D.O.O.

SI

not available

H/93/00621/007

GLAXOSMITHKLINE D.O.O.

SI

not available

H/94/00620/001

GLAXOSMITHKLINE D.O.O.

SI

not available

H/94/00620/003

GLAXOSMITHKLINE D.O.O.

SI

UK/H/5780/001

54029

DK

Flixonase Allergy 50 micrograms/actuation nasal spray, suspension Flonase 50 micrograme/doza spray nazal suspensie Flixotide 250 Inhaler N inhalačná suspenzia v tlakovom obale Flixotide 125 Inhaler N inhalačná suspenzia v tlakovom obale Flixonase Allergia 50 mikrogramm/adag szuszpenziós orrspray

UK/H/5780/001

MA575/00901

GLAXOSMITHKLINE CONSUMER HEALTHCARE A/S GLAXOSMITHKLINE EXPORT LTD

UK/H/5780/001

7856/2015/01

RO

not available

14/0142/15-S

GLAXOSMITHKLINE CONSUMER HEALTHCARE S.R.L. GLAXO GROUP LIMITED

not available

14/0141/15-S

GLAXO GROUP LIMITED

SK

UK/H/5780/001

OGYI-T-22848/01

GLAXOSMITHKLINECONSUMER KFT.

HU

List of nationally authorised medicinal products EMA/846273/2017

MT

SK

Page 19/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH & CO. KG GLAXOSMITHKLINE CONSUMER HEALTHCARE (IRELAND) LTD GLAXOSMITHKLINE CONSUMER HEALTHCARE A/S GLAXOSMITHKLINE CONSUMER HEALTHCARE, PRODUTOS PARA A SAÚDE E HIGIENE, LDA GLAXOSMITHKLINE CONSUMER HEALTHCARE CZECH REPUBLIC S.R.O. GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED GLAXOSMITHKLINE CONSUMER HEALTHCARE (IRELAND) LTD GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED

DE

GLAXOSMITHKLINE CONSUMER HEALTHCARE CZECH REPUBLIC S.R.O. GLAXOSMITHKLINE CONSUMER HEALTHCARE S.P.A.

CZ

number Flixonase 50 Mikrogramm / Sprühstoß Nasenspray, Suspension Flixonase Allergy Relief 50 micrograms per dose Nasal Spray Flutide 50 mikrogrammaa/annos nenäsumute, suspensio Flonaze 50 microgramas/dose suspensão para pulverização nasal Flutikazónpropionát GSK 50 mikrogramov Nosová suspenzná aerodisperzia Flixonase, 50 mikrogrammi/pihustuses ninasprei, suspensioon Fluticasone propionate 50 micrograms/actuation nasal spray, suspension Flixonase 50 mikrogrami/ izsmidzinājumā deguna aerosols, suspensija Flixonase 50 mikrogramů/dávka nosní sprej, suspenze Fluticasone GSK Consumer Healthcare 50 microgrammi/erogazione spray nasale, sospensione

UK/H/5780/001

92297.00.00

not available

PA 0678/095/001

UK/H/5780/001

32208

UK/H/5780/001

5658323

UK/H/5780/001

69/0336/15-S

UK/H/5780/001

878315

UK/H/5780/001

PA 678/118/1

UK/H/5780/001

15-0221

UK/H/5780/001

24/444/15-C

UK/H/5780/001

043645011

List of nationally authorised medicinal products EMA/846273/2017

IE FI PT

SK EE IE LV

IT

Page 20/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixotide Nebules 0,5 mg/2 ml suspensie de inhalat prin nebulizator Flixonase 50 mikrogramų/išpurškime nosies purškalas (suspensija) Flixonase GSK ConsHealth 50 microgram/dosis, neusspray suspensie Flonase Allergy, 50 mikrogramów/dawkę, aerozol do nosa, zawiesina Flixotide 50 micrograms Evohaler Flixotide Nebules 0.5mg/2ml Flixotide Nebules 2mg/2ml Cutivate 0.005% w/w Ointment

not available

1117/2008/01

GLAXO WELLCOME UK LIMITED

RO

UK/H/5780/001

LT/1/15/3806/001

GLAXOSMITHKLINE EXPORT LTD

LT

UK/H/5780/001

RVG 115221

GLAXOSMITHKLINE CONSUMER HEALTHCARE B.V

NL

UK/H/5780/001

22862

GLAXOSMITHKLINE CONSUMER HEALTHCARE SP. Z O.O.

PL

not available

PL 10949/0324

UK

not available

PL 10949/0297

not available

PL 10949/0298

not available

PL 10949/0012

Cutivate 0,05 mg/g pomada Cutivate 0.05% w/w Cream

not available

80.357

GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK STIEFEL FARMA, S.A.

not available

MA 167/00501

MT

Cutivate 0.005% w/w Ointment

not available

MA167/00502

GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK

List of nationally authorised medicinal products EMA/846273/2017

UK UK UK ES

MT

Page 21/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixotide Evohaler 125 micrograms per metered dose, Pressurised Inhalation Suspension Flixotide Evohaler 250 micrograms per metered dose, Pressurised Inhalation Suspension Flixotide Evohaler 50 micrograms per metered dose, Pressurised Inhalation Suspension Flixonase, næsedråber, suspension, enkeltdosisbeholder Flixonase 400 microgramos, gotas nasales en suspensión Flixonase 400 mikrog (1mg/ml), nenätipat, suspensio Flixonase 400 microgram (1 mg/ml), neusdruppels, suspensie Flutide Nasal 400 mikrogram (1 mg/ml) näsdroppar, suspension Flixonase® Nasule® Drops 400 micrograms (1 mg/ml), nasal drops suspension Flixotide Diskus 250 mikrogrami pulveris inhalācijām

not available

MA 192/00402

GLAXOSMITHKLINE (IRELAND) LIMITED

MT

not available

MA 192/00403

GLAXOSMITHKLINE (IRELAND) LIMITED

MT

not available

MA 192/00401

GLAXOSMITHKLINE (IRELAND) LIMITED

MT

DK/H/0142/001

30162

GLAXOSMITHKLINE PHARMA A/S

DK

DK/H/0142/001

62.771

GLAXOSMITHKLINE S.A.

ES

DK/H/0142/001

13796

GLAXOSMITHKLINE OY

FI

DK/H/0142/001

RVG 23477

GLAXOSMITHKLINE B.V.

NL

DK/H/0142/001

14911

GLAXOSMITHKLINE AB

SE

DK/H/0142/001

PL 10949/0323

GLAXO WELLCOME UK LIMITED

UK

not available

99-0396

GLAXOSMITHKLINE LATVIA SIA

LV

List of nationally authorised medicinal products EMA/846273/2017

Page 22/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised AT

number Cutivate 0,05 %-Creme

not available

1-20994

Flixonase Aqueous Nasal Spray Flixotide 250 Inhaler N Suspenze k inhalaci v tlakovém obalu Кутиват 0,005 % маз Flixotide 50 Inhaler N Suspenze k inhalaci v tlakovém obalu Flixotide 250 mikrogramų/dozėje suslėgtoji įkvepiamoji suspensija Fluticasone Propionate GSK 50 mikrogramų/išpurškime nosies purškalas (suspensija) Flutide® Nasal 0,05 mg/Sprühstoß Nasenspray, Suspension Flixotide Diskus 250 mikrogramų/dozėje dozuoti įkvepiamieji milteliai Flutide - 1 Aerosol Druckgasinhalation, Suspension Flutide  mit Dosier-Aerosol Druckgasinhalation, Suspension

not available

MA 167/01901

GLAXOSMITHKLINE PHARMA GMBH. GLAXO WELLCOME LTD

not available

14/059/00-C

GLAXO GROUP LIMITED

CZ

not available not available

20010845 14/066/00-C

GLAXO GROUP LIMITED GLAXO GROUP LIMITED

BG CZ

not available

LT/1/94/1013/004

GLAXOSMITHKLINE LIETUVA UAB

LT

not available

LT/1/94/0977/002

GLAXOSMITHKLINE LIETUVA UAB

LT

not available

23247.00.00

GLAXOSMITHKLINE GMBH & CO. KG

DE

not available

LT/1/95/1014/003

GLAXOSMITHKLINE LIETUVA UAB

LT

not available

39639.02.00

GLAXOSMITHKLINE GMBH & CO. KG

DE

not available

39639.01.00

GLAXOSMITHKLINE GMBH & CO. KG

DE

List of nationally authorised medicinal products EMA/846273/2017

MT

Page 23/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXOSMITHKLINE GMBH & CO. KG GLAXOSMITHKLINE B.V.

DE

number Flutivate® Creme 0,5 mg/1 g Flixotide 50 Inhalator CFK-vrij, aërosol, suspensie 50 microgram/dosis Flixotide Diskus 250 microgrammes/dose Poudre pour inhalation en récipient unidose Flixotide Nebules 2mg/2ml - Suspension pour inhalation par nébuliseur Flixotide Nebules 0,5mg/2ml - Suspension pour inhalation par nébuliseur Flixotaide Diskus 100 microgramas/dose pó para inalação Flixotaide Inalador 125 microgramas/dose suspensão pressurizada para inalação Flixotaide Inalador 250 microgramas/dose suspensão pressurizada para inalação Flixotide Diskus 500 micrograme pulbere de inhalat Flixotide Diskus 250 micrograme pulbere de inhalat

not available

30167.00.00

not available

RVG 16212

not available

2007 09 9446

GLAXOSMITHKLINE PHARMACEUTICALS SA

LU

not available

2007 09 9449

GLAXOSMITHKLINE PHARMACEUTICALS SA

LU

not available

2007 09 9448

GLAXOSMITHKLINE PHARMACEUTICALS SA

LU

not available

2625283

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

not available

2224582

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

not available

2224681

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

not available

2338/2010/01

GLAXO WELLCOME UK LIMITED

RO

not available

2337/2010/01

GLAXO WELLCOME UK LIMITED

RO

List of nationally authorised medicinal products EMA/846273/2017

NL

Page 24/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number FLIXOTIDE Cutivate mast 0,05 mg/g fluticasoni propionas Flixotide Diskus 250 microgram/dosis inhalatiepoeder, voorverdeeld Fluinol 50 microgramos/pulverizaci ón, suspensión para pulverización nasal FLIXOTIDE FLIXOTIDE Flixotide 250 microgrammes/doseSuspension pour inhalation en flacon pressurisé Flixotaide Diskus 500 microgramas/dose pó para inalação Flixotide Dysk, 50 mg/dawkę inhalacyjną, proszek do inhalacji Cutivate 0,5 mg/g, krem

not available not available

2067903 46/659/94-C

GLAXO GROUP LIMITED GLAXO GROUP LIMITED

GR CZ

not available

RVG 18194

GLAXOSMITHKLINE BV

NL

not available

60.542

GLAXOSMITHKLINE S.A.

ES

not available not available not available

2067907 2067908 2007 09 9440

GLAXO GROUP LIMITED GLAXO GROUP LIMITED GLAXOSMITHKLINE PHARMACEUTICALS SA

GR GR LU

not available

2625689

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

not available

4845

GLAXOSMITHKLINE EXPORT LTD

PL

not available

R/3650

PL

FLIXOTIDE INHALER, 50 mikrogrammi/annuses inhalatsiooniaerosool, suspensioon Flixotide 50 mikrogramų/dozėje suslėgtoji įkvepiamoji suspensija

not available

098995

GLAXOSMITHKLINE EXPORT LTD GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK

not available

LT/1/94/1013/001

GLAXOSMITHKLINE LIETUVA UAB

LT

List of nationally authorised medicinal products EMA/846273/2017

EE

Page 25/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXOSMITHKLINE AB GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LIMITED

SE RO

number Flutivate 0,05 % kräm FLIXONASE 0,05 g/100 g spray nazal suspensie Flixotide Diskus 100 micrograme pulbere de inhalat Flixotide Diskus® junior 100 Mikrogramm Pulver zur Trockeninhalation Flixotide Diskus 500 micrograme pulbere de inhalat Flixonase aquosum – Nasenspray Flixotide standard 125 Mikrogramm – Dosieraerosol Flixotide junior 50 Mikrogramm Dosieraerosol Flixotide forte 250 Mikrogramm Dosieraerosol Flixotide Diskus® forte 500 Mikrogramm Pulver zur Trockeninhalation Flixotide Diskus® standard 250 Mikrogramm - Pulver zur Trockeninhalation Кутиват 0,05 % крем

not available not available

11905 6605/2014/01

not available

2336/2010/02

not available

1-20577

GLAXOSMITHKLINE PHARMA GMBH.

AT

not available

2338/2010/02

GLAXO WELLCOME UK LIMITED

RO

not available

1-19708

AT

not available

1-20555

GLAXOSMITHKLINE PHARMA GMBH. GLAXOSMITHKLINE PHARMA GMBH.

not available

1-20552

GLAXOSMITHKLINE PHARMA GMBH.

AT

not available

1-20559

GLAXOSMITHKLINE PHARMA GMBH.

AT

not available

1-20578

GLAXOSMITHKLINE PHARMA GMBH.

AT

not available

1-20575

GLAXOSMITHKLINE PHARMA GMBH.

AT

not available

20010846

GLAXO GROUP LIMITED

BG

List of nationally authorised medicinal products EMA/846273/2017

RO

AT

Page 26/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Фликсоназе 50 микрограма/дозирано впръскване, спрей за нос, суспензия FLIXOTIDE FLIXOTIDE FLIXOTIDE FLIXOTIDE FLIXOTIDE Flixotide 125 mikrogrami/devā aerosols inhalācijām, zem spiediena, suspensija CUTIVATE 0,5 mg/g krēms Flixotide Diskus 500 mikrogrami pulveris inhalācijām FLIXONASE Nasule Drops 400 mikrogrami deguna pilieni, suspensija Flixotide Diskus 100 mikrogrami pulveris inhalācijām CUTIVATE 0,05 mg/g ziede Flixotide 50 mikrogrami/devā aerosols inhalācijām, zem spiediena, suspensija

not available

20030010

GLAXO GROUP LIMITED

BG

not not not not not not

38971/10/18-4-2011 2067909 38968/10/18-4-2011 2067904 2067905 02-0134

GLAXOSMITHKLINE AEBE GLAXO GROUP LIMITED GLAXOSMITHKLINE AEBE GLAXO GROUP LIMITED GLAXO GROUP LIMITED GLAXOSMITHKLINE LATVIA SIA

GR GR GR GR GR LV

not available

00-0252

LV

not available

99-0397

GLAXOSMITHKLINE LATVIA SIA GLAXOSMITHKLINE LATVIA SIA

not available

02-0266

GLAXOSMITHKLINE LATVIA SIA

LV

not available

99-0395

GLAXOSMITHKLINE LATVIA SIA

LV

not available

00-0251

LV

not available

02-0133

GLAXOSMITHKLINE LATVIA SIA GLAXOSMITHKLINE LATVIA SIA

available available available available available available

List of nationally authorised medicinal products EMA/846273/2017

LV

LV

Page 27/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixotide 250 mikrogrami/devā aerosols inhalācijām, zem spiediena, suspensija FLIXOTIDE DISKUS 50 MCG, 50 mikrogrammi/annuses inhalatsioonipulber Cutivate 0,05 mg/g tepalas Flutide Diskus 250 mikrogram/dos inhalationspulver, avdelad dos Flutide Evohaler 50 mikrogram/dos inhalationsspray, suspension Flutide Diskus 100 mikrogram/dos inhalationspulver, avdelad dos Flixotide Diskus 100 micrograme pulbere de inhalat Flixotide, inhalationsspray, suspension Flixotide

not available

02-0135

GLAXOSMITHKLINE LATVIA SIA

LV

not available

108695

GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK

EE

not available

LT/1/94/0477/001

LT

not available

12418

GLAXOSMITHKLINE LIETUVA UAB GLAXOSMITHKLINE AB

not available

18728

GLAXOSMITHKLINE AB

SE

not available

12417

GLAXOSMITHKLINE AB

SE

not available

2336/2010/01

GLAXO WELLCOME UK LIMITED

RO

not available

14984

GLAXOSMITHKLINE PHARMA A/S

DK

not available

16826

DK

Flixotide 125 Inhaler N Suspenze k inhalaci v tlakovém obalu

not available

14/058/00-C

GLAXOSMITHKLINE PHARMA A/S GLAXO GROUP LIMITED

List of nationally authorised medicinal products EMA/846273/2017

SE

CZ

Page 28/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Cutivate krém 0,5 mg/g fluticasoni propionas Flixotide Diskus 500 Dávkovaný prášek k inhalaci Flixonase 50 mikrog/annos nenäsumute, suspensio FLIXOTIDE DISKUS 100 MCG, 100 mikrogrammi/annuses inhalatsioonipulber FLIXOTIDE DISKUS 250 MCG, 250 mikrogrammi/annuses inhalatsioonipulber FLIXONASE AQUEOUS NASAL SPRAY 50 MCG, 50 mikrogrammi ninasprei, suspensioon Cutivate 0,5 mg/g kremas Fluticasone Propionate GSK 50 mikrogramų/išpurškime nosies purškalas (suspensija) Cutivate 0,5 mg/g kremas Flixotide 50 mikrogramų/dozėje suslėgtoji įkvepiamoji suspensija

not available

46/658/94-C

GLAXO GROUP LIMITED

CZ

not available

14/076/00-C

GLAXO GROUP LIMITED

CZ

not available

10831

FI

not available

108795

GLAXOSMITHKLINE CONSUMER HEALTHCARE A/S GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK

not available

108895

GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK

EE

not available

098795

GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK

EE

not available

LT/1/94/0477/002

LT

not available

LT/1/94/0977/003

GLAXOSMITHKLINE LIETUVA UAB GLAXOSMITHKLINE LIETUVA UAB

not available

LT/1/94/0477/004

LT

not available

LT/1/94/1013/002

GLAXOSMITHKLINE LIETUVA UAB GLAXOSMITHKLINE LIETUVA UAB

List of nationally authorised medicinal products EMA/846273/2017

EE

LT

LT

Page 29/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXOSMITHKLINE LIETUVA UAB GLAXOSMITHKLINE LIETUVA UAB

LT

number Cutivate 0,05 mg/g tepalas Flixotide Diskus 500 mikrogramų/dozėje dozuoti įkvepiamieji milteliai Flixotide Diskus 50 mikrogramų/dozėje dozuoti įkvepiamieji milteliai Flixotide 125 mikrogramai/dozėje suslėgtoji įkvepiamoji suspensija Flixotide Diskus 100 mikrogramų/dozėje dozuoti įkvepiamieji milteliai Otri-Allergie® Nasenspray Fluticason 0,05 mg Fluticasonpropionat/Sprü hstoß Nasenspray, Suspension Für Erwachsene Cutivate zalf 0,05 mg/g Cutivate crème 0,5 mg/g Flixotide 125 Inhalator CFK-vrij, aërosol, suspensie 125 microgram/dosis Flixotide Diskus 100 microgram/dosis inhalatiepoeder, voorverdeeld

not available

LT/1/94/0477/003

not available

LT/1/95/1014/004

not available

LT/1/95/1014/001

GLAXOSMITHKLINE LIETUVA UAB

LT

not available

LT/1/94/1013/003

GLAXOSMITHKLINE LIETUVA UAB

LT

not available

LT/1/95/1014/002

GLAXOSMITHKLINE LIETUVA UAB

LT

not available

23248.00.00

GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH & CO. KG

DE

not available not available not available

RVG 16648 RVG 16647 RVG 16213

GLAXOSMITHKLINE BV GLAXOSMITHKLINE BV GLAXOSMITHKLINE B.V.

NL NL NL

not available

RVG 18193

GLAXOSMITHKLINE BV

NL

List of nationally authorised medicinal products EMA/846273/2017

LT

Page 30/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixotide Diskus 500 microgram/dosis inhalatiepoeder, voorverdeeld Flixotide 250 Inhalator CFK-vrij, aërosol, suspensie 250 microgram/dosis Flixonase 50 microgram per dosis, neusspray suspensie FLIXONASE AQUA, 50 microgrammes/dose, suspension pour pulvérisation nasale Flixotide Diskus 500 microgrammes/dose Poudre pour inhalation en récipient unidose Flixotide Diskus 100 microgrammes/dose Poudre pour inhalation en récipient unidose Cutivate 0,05 mg/g Pomada Cutivate 0,5 mg/g Creme

not available

RVG 18195

GLAXOSMITHKLINE BV

NL

not available

RVG 16214

GLAXOSMITHKLINE B.V.

NL

not available

RVG 14424

GLAXOSMITHKLINE B.V.

NL

not available

260/09 08 0497

GLAXOSMITHKLINE PHARMACEUTICALS SA

LU

not available

2007 09 9447

GLAXOSMITHKLINE PHARMACEUTICALS SA

LU

not available

2007 09 9445

GLAXOSMITHKLINE PHARMACEUTICALS SA

LU

not available

2219889

PT

not available

2219780

Flixotaide Diskus 250 microgramas/dose pó para inalação Flixotaide Inalador 250 microgramas/dose suspensão pressurizada para inalação

not available

2625481

GLAXO WELLCOME FARMACÊUTICA, LDA GLAXO WELLCOME FARMACÊUTICA, LDA GLAXO WELLCOME FARMACÊUTICA, LDA

not available

2224780

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

List of nationally authorised medicinal products EMA/846273/2017

PT PT

Page 31/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixotaide Diskus 50 microgramas/dose pó para inalação Flutaide 50 microgramas/dose suspensão para pulverização nasal Flixotaide Inalador 50 microgramas/dose suspensão pressurizada para inalação Flutide Diskus 500 mikrogram/dos inhalationspulver, avdelad dos Flutide Diskus 50 mikrogram/dos inhalationspulver, avdelad dos Flutide Evohaler 125 mikrogram/dos inhalationsspray, suspension Flutide Nasal 50 mikrogram/dos nässpray, suspension Flixotide Diskus 250 micrograme pulbere de inhalat Flixotide 125 Inhaler CFC-Free, suspensie de inhalat presurizată Flixotide 250 Inhaler CFC-Free, suspensie de inhalat presurizată

not available

2625085

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

not available

2223980

ALENFARMA ESPECIALIDADES FARMACEUTICAS, LDA

PT

not available

2224384

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

not available

12419

GLAXOSMITHKLINE AB

SE

not available

12416

GLAXOSMITHKLINE AB

SE

not available

13408

GLAXOSMITHKLINE AB

SE

not available

11327

GLAXOSMITHKLINE AB

SE

not available

2337/2010/02

GLAXO WELLCOME UK LIMITED

RO

not available

623/2008/02

GLAXO WELLCOME UK LIMITED

RO

not available

624/2008/01

GLAXO WELLCOME UK LIMITED

RO

List of nationally authorised medicinal products EMA/846273/2017

Page 32/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixotide 50 Inhaler CFCFree, suspensie de inhalat presurizată Flixotide Nebules 2 mg/2 ml suspensie de inhalat prin nebulizator Flixotide Nebules 2 mg/2 ml suspensie de inhalat prin nebulizator Flixotide Nebules 0,5 mg/2 ml suspensie de inhalat prin nebulizator Cutivate 0,5 mg/g crema Cutivate, 0,05 mg/g, maść Flixonase Nasule, 400 µg/dawky (I mg/ml), krople do nosa, zawiesina Flixonase, 50 µg/dawkę, aerozol do nosa, zawiesina Flixotide Dysk, 500 mg/dawkę inhalacyjną, proszek do inhalacji Flixotide, 0,5 mg/2 ml, zawiesina do nebulizacji Flixotide, 2 mg/2 ml, zawiesina do nebulizacji Flixotide Dysk, 100 mg/dawkę inhalacyjną, proszek do inhalacji Flixotide, 250 mg/dawkę inhalacyjną, aerozol inhalacyjny, zawiesina

not available

4685/2004/01

GLAXO WELLCOME UK LIMITED

RO

not available

1118/2008/02

GLAXO WELLCOME UK LIMITED

RO

not available

1118/2008/01

GLAXO WELLCOME UK LIMITED

RO

not available

1117/2008/02

GLAXO WELLCOME UK LIMITED

RO

not available not available

60.218 R/3651

ES PL

not available

9338

STIEFEL FARMA, S.A. GLAXOSMITHKLINE EXPORT LTD GLAXOSMITHKLINE EXPORT LTD

not available

R/2948

GLAXOSMITHKLINE EXPORT LTD

PL

not available

4848

GLAXOSMITHKLINE EXPORT LTD

PL

not available

9565

PL

not available

9566

not available

4846

GLAXOSMITHKLINE EXPORT LTD GLAXOSMITHKLINE EXPORT LTD GLAXOSMITHKLINE EXPORT LTD

not available

8515

GLAXOSMITHKLINE EXPORT LTD

PL

List of nationally authorised medicinal products EMA/846273/2017

PL

PL PL

Page 33/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixotide 50 micrograms Evohaler Cutivate Cream 0.05% Flixotide Diskus 250 micrograms (fluticasone propionate) Flixotide Diskus 100 micrograms (fluticasone propionate) Flixotide

not available

16810

GLAXO GROUP LIMITED

CY

not available not available

16799 19606

GLAXO GROUP LIMITED GLAXO GROUP LIMITED

CY CY

not available

19556

GLAXO GROUP LIMITED

CY

not available

14982

PHARMA

DK

Flixotide

not available

14983

PHARMA

DK

Flixotide

not available

16828

PHARMA

DK

Flixotide

not available

16825

PHARMA

DK

Flixotide

not available

16827

PHARMA

DK

FLIXOTIDE 50 microgrammes/dose, suspension pour inhalation en flacon pressurisé FLIXOTIDE DISKUS 500 microgrammes/dose, poudre pour inhalation FLIXOTIDE DISKUS 100 microgrammes/dose, poudre pour inhalation FLIXOTIDE DISKUS 50 microgrammes/dose, poudre pour inhalation buccale

not available

NL18773

GLAXOSMITHKLINE A/S GLAXOSMITHKLINE A/S GLAXOSMITHKLINE A/S GLAXOSMITHKLINE A/S GLAXOSMITHKLINE A/S LABORATOIRE GLAXOSMITHKLINE

not available

NL20892

LABORATOIRE GLAXOSMITHKLINE S.A.S.

FR

not available

NL20890

LABORATOIRE GLAXOSMITHKLINE S.A.S.

FR

not available

NL20885

LABORATOIRE GLAXOSMITHKLINE

FR

List of nationally authorised medicinal products EMA/846273/2017

S.A.S.

FR

Page 34/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number FLIXOTIDE 125 microgrammes/dose, suspension pour inhalation en flacon pressurisé FLIXONASE 50 microgrammes/dose, suspension nasale en flacon pulvérisateur avec pompe doseuse FLIXOTIDE 250 microgrammes/dose, suspension pour inhalation en flacon pressurisé FLIXOTIDE DISKUS 250 microgrammes/dose, poudre pour inhalation Flixotide Evohaler 125 mikrogramm/adag túlnyomásos inhalációs szuszpenzió Flixotide Diskus 100 mikrogramm/adag adagolt inhalációs por Flixotide Diskus 250 mikrogramm/adag adagolt inhalációs por Flixotide Diskus 500 mikrogramm/adag adagolt inhalációs por Cutivate 0,05 mg/g kenőcs Cutivate 0,5 mg/g krém

not available

NL18774

LABORATOIRE GLAXOSMITHKLINE S.A.S.

FR

not available

NL16604

LABORATOIRE GLAXOSMITHKLINE S.A.S.

FR

not available

NL18775

LABORATOIRE GLAXOSMITHKLINE S.A.S.

FR

not available

NL20891

LABORATOIRE GLAXOSMITHKLINE S.A.S.

FR

not available

OGYI-T-7825/01

GLAXOSMITHKLINE KFT.

HU

not available

OGYI-T-5999/01

GLAXOSMITHKLINE KFT.

HU

not available

OGYI-T-5999/02

GLAXOSMITHKLINE KFT.

HU

not available

OGYI-T-5999/03

GLAXOSMITHKLINE KFT.

HU

not available

OGYI-T-5405/01

GLAXOSMITHKLINE KFT.

HU

not available

OGYI-T-5406/01

GLAXOSMITHKLINE KFT.

HU

List of nationally authorised medicinal products EMA/846273/2017

Page 35/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixonase szuszpenziós orrspray FLIXODERM 0,005% Unguento FLIXONASE 50 microgrammi/erogazione Spray Nasale, Sospensione FLIXODERM 0,05% Crema FLIXOTIDE 250 mcg Sospensione pressurizzata per inalazione FLIXOTIDE 250 mcg Polvere per inalazione FLIXOTIDE 50 mcg Sospensione pressurizzata per inalazione FLIXOTIDE 500 mcg/2 ml Sospensione da nebulizzare FLIXONASE 50 microgrammi/erogazione Spray Nasale, Sospensione FLIXOTIDE 100 mcg Polvere per inalazione FLIXOTIDE 125 mcg Sospensione pressurizzata per inalazione FLIXOTIDE 500 mcg Polvere per inalazione

not available

OGYI-T-2380/01

GLAXOSMITHKLINE KFT.

HU

not available

029014038

GLAXOSMITHKLINE S.P.A.

IT

not available

027657042

GLAXOSMITHKLINE S.P.A.

IT

not available

029014014

GLAXOSMITHKLINE S.P.A.

IT

not available

028667107

GLAXOSMITHKLINE S.P.A.

IT

not available

028667184

GLAXOSMITHKLINE S.P.A.

IT

not available

028667020

GLAXOSMITHKLINE S.P.A.

IT

not available

028667210

GLAXOSMITHKLINE S.P.A.

IT

not available

027657016

GLAXOSMITHKLINE S.P.A.

IT

not available

028667160

GLAXOSMITHKLINE S.P.A.

IT

not available

028667095

GLAXOSMITHKLINE S.P.A.

IT

not available

028667208

GLAXOSMITHKLINE S.P.A.

IT

List of nationally authorised medicinal products EMA/846273/2017

Page 36/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXOSMITHKLINE SLOVAKIA S.R.O. GLAXO GROUP LIMITED

SK

GLAXO GROUP LIMITED GLAXOSMITHKLINE PHARMA A/S GLAXOSMITHKLINE PHARMA A/S

SK IS

number Flixonase Nasal Drops

not available

69/0116/01-S

Flixonase Aqueous Nasal Spray 50 µg/1 dávka nosová suspenzná aerodisperzia Flixotide 50 Inhaler N Flutivate 0,05% krem

not available

24/0796/92-C/S

not available not available

14/0372/95-S 920155 (IS)

Flixotide 125 míkróg/skammt innúðalyf, dreifa Flixotide Diskus 250 míkróg/skammt innöndunarduft, afmældir skammtar Flixotide Diskus 100 míkróg/skammt innöndunarduft, afmældir skammtar Flixonase 50 míkróg/skammt nefúði, dreifa Flixotide 250 míkróg/skammt innúðalyf, dreifa Flixotide Diskus 500 míkróg/skammt innöndunarduft, afmældir skammtar Flixotide 50 míkróg/skammt innúðalyf, dreifa

not available

920141 (IS)

not available

940265 (IS)

GLAXOSMITHKLINE PHARMA A/S

IS

not available

940264 (IS)

GLAXOSMITHKLINE PHARMA A/S

IS

not available

890173 (IS)

GLAXOSMITHKLINE PHARMA A/S

IS

not available

920140 (IS)

GLAXOSMITHKLINE PHARMA A/S

IS

not available

940266 (IS)

GLAXOSMITHKLINE PHARMA A/S

IS

not available

920142 (IS)

GLAXOSMITHKLINE PHARMA A/S

IS

List of nationally authorised medicinal products EMA/846273/2017

SK

IS

Page 37/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flutide 125 mikrogram/dose inhalasjonsaerosol, suspensjon Flutide inhalasjonspulver 100 mikrogram/dose Flutide 250 mikrogram/dose inhalasjonsaerosol, suspensjon Flutide Nasal 50 mikrog/dose, nesespray, suspensjon Flutivate 0,05 % krem Flutivate Flutide inhalasjonspulver 500 mikrogram/dose Flutide 50 mikrogram/dose inhalasjonsaerosol, suspensjon Flutide inhalasjonspulver 50 mikrogram/dose Flutide inhalasjonspulver 250 mikrogram/dose INALACOR Accuhaler 500 mg, Polvo para inhalación Pirinase Hayfever Relief for Adults 0.05% Nasal Spray Flixonase Allergy Nasal Spray

not available

96-3187

GLAXOSMITHKLINE AS

NO

not available

94-03023

GLAXOSMITHKLINE AS

NO

not available

96-3188

GLAXOSMITHKLINE AS

NO

not available

7960

GLAXOSMITHKLINE AS

NO

not available not available not available

8154 8155 94-03028

GLAXOSMITHKLINE AS GLAXOSMITHKLINE AS GLAXOSMITHKLINE AS

NO NO NO

not available

94-01759

GLAXOSMITHKLINE AS

NO

not available

94-03022

GLAXOSMITHKLINE AS

NO

not available

94-03026

GLAXOSMITHKLINE AS

NO

not available

60.691

ALLEN FARMACÉUTICA, S.A

ES

not available

PL 44673/0100

UK

not available

PL 44673/0099

GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED

List of nationally authorised medicinal products EMA/846273/2017

UK

Page 38/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flutikazonpropionat GSK 50 mikrogramov/vpih pršilo za nos, suspenzija Flonase 50 microgramos/pulverizaci ón, suspensión para pulverización nasal FLIXONASE AQUEOUS NASAL SPRAY 50 MCG, 50 mikrogrammi ninasprei, suspensioon Flixotide 500 Nebules, vernevelsuspensie 0,5 mg/2 ml FLIXOTIDE NASULE Flixotide Flixotide 2000 Nebules, vernevelsuspensie 2 mg/2 ml Flutivate 0,005% smyrsli

UK/H/5780/001

H/16/02160/001

GLAXOSMITHKLINE D.O.O.

SI

UK/H/5780/001

79947

GLAXOSMITHKLINE CONSUMER HEALTHCARE, S.A.

ES

not available

810413

GLAXO WELLCOME LTD

EE

not available

RVG 21834

GLAXOSMITHKLINE B.V.

NL

not available not available not available

2442001 83344/26-11-2014 RVG 21835

GLAXOSMITHKLINE AEBE GLAXOSMITHKLINE AEBE GLAXOSMITHKLINE B.V.

GR GR NL

not available

920154 (IS)

IS

CUTIVATE OINTMENT 0,005%, salv FLIXOVATE 0,005 POUR CENT, pommade Flutide Nasal 1 mg/ml, nesedråper, suspensjon Flixotide, 50 mg/dawkę inhalacyjną, aerozol inhalacyjny, zawiesina Flixotide, 125 mg/dawkę inhalacyjną, aerozol inhalacyjny, zawiesina

not available

098595

GLAXOSMITHKLINE PHARMA A/S GLAXO WELLCOME LTD

not available

NL19271

FR

not available

98-3816

LABORATOIRE GLAXOSMITHKLINE S.A.S. GLAXOSMITHKLINE AS

not available

8513

GLAXOSMITHKLINE EXPORT LTD

PL

not available

8514

GLAXOSMITHKLINE EXPORT LTD

PL

List of nationally authorised medicinal products EMA/846273/2017

EE

NO

Page 39/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flixonase 50 microgramos/pulverizaci ón, suspensión para pulverización nasal INALACOR 250 mg, Suspensión para inhalación en envase a presión INALACOR Accuhaler 100 mg, Polvo para inhalación Flixonase 0.05% Nasal Spray

not available

60.483

GLAXOSMITHKLINE S.A.

ES

not available

60.688

ALLEN FARMACÉUTICA, S.A

ES

not available

60.689

ALLEN FARMACÉUTICA, S.A

ES

not available

PL 44673/0101

UK

Fluticasone propionate 50 micrograms/actuation nasal spray, suspension FLIXOVATE 0,05 POUR CENT, crème CUTIVATE CREAM 0,05%, kreem Flixonase, næsespray, suspension, 60 doser Flixotide Accuhaler 50 micrograms Flixotide Accuhaler 100 micrograms Flixotide Accuhaler 500 micrograms Flixotide Accuhaler 250 micrograms Flixotide 250 micrograms Evohaler Flixotide 125 micrograms Evohaler

UK/H/5780/001

PL 44673/0102

not available

NL19270

not available

098495

GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) TRADING LIMITED LABORATOIRE GLAXOSMITHKLINE S.A.S. GLAXO WELLCOME LTD

not available

13680

DK

not available

PL 10949/0226

not available

PL 10949/0227

not available

PL 10949/0229

not available

PL 10949/0228

not available

PL 10949/0266

not available

PL 10949/0265

GLAXOSMITHKLINE PHARMA A/S GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LIMITED

List of nationally authorised medicinal products EMA/846273/2017

UK FR EE

UK UK UK UK UK UK

Page 40/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK GLAXOSMITHKLINE (IRELAND) LIMITED GLAXOSMITHKLINE (IRELAND) LIMITED

UK

number Cutivate 0.05% w/w Cream

not available

PL 10949/0013

Flixotide Nebules 2 mg/2 ml Nebuliser Suspension Flixotide Evohaler 50 micrograms per metered dose, Pressurised Inhalation Suspension Flixotide Evohaler 250 micrograms per metered dose, Pressurised Inhalation Suspension Flixotide Diskus 500 micrograms, Inhalation Powder, pre-dispensed Flixotide Evohaler 125 micrograms per metered dose, Pressurised Inhalation Suspension Flixotide Diskus 100 micrograms, Inhalation Powder, pre-dispensed Flixotide Diskus 250 micrograms, Inhalation Powder, pre-dispensed Flixotide Diskus 50 micrograms, Inhalation Powder, pre-dispensed Flixotide Nebules 0.5 mg/2 ml Nebuliser Suspension

not available

PA 1077/044/017

not available

PA 1077/044/013

not available

PA 1077/044/015

GLAXOSMITHKLINE (IRELAND) LIMITED

IE

not available

PA 1077/044/012

GLAXOSMITHKLINE (IRELAND) LIMITED

IE

not available

PA 1077/044/014

GLAXOSMITHKLINE (IRELAND) LIMITED

IE

not available

PA 1077/044/010

GLAXOSMITHKLINE (IRELAND) LIMITED

IE

not available

PA 1077/044/011

GLAXOSMITHKLINE (IRELAND) LIMITED

IE

not available

PA 1077/044/009

GLAXOSMITHKLINE (IRELAND) LIMITED

IE

not available

PA 1077/044/016

GLAXOSMITHKLINE (IRELAND) LIMITED

IE

List of nationally authorised medicinal products EMA/846273/2017

IE IE

Page 41/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Flutide  25 not 250 μg/Dosis, einzeldosiertes Pulver zur Inhalation Flutide  mite not Diskus  100 μg/Dosis, einzeldosiertes Pulver zur Inhalation Flutide  forte not Diskus  500 μg/Dosis, einzeldosiertes Pulver zur Inhalation Flutide  Junio not Diskus  50 μg/Dosis, einzeldosiertes Pulver zur Inhalation Flixotide Nebules not 0.5mg/2ml Flixotide Diskus 500 µg not inhalacny prasok Flixotaide Nebules, 0,5 not mg/ 2 ml, suspensão para inalação por nebulização Flixotaide Nebules, 2 not mg/ 2 ml, suspensão para inalação por nebulização Flixonase Aqueous Nasal not Spray Flixotide 125 micrograms not Evohaler

available

30864.02.00

GLAXOSMITHKLINE GMBH & CO. KG

DE

available

30864.01.00

GLAXOSMITHKLINE GMBH & CO. KG

DE

available

30867.00.00

GLAXOSMITHKLINE GMBH & CO. KG

DE

available

30864.00.00

GLAXOSMITHKLINE GMBH & CO. KG

DE

available

18620

GLAXO GROUP LIMITED

CY

available

14/0145/15-S

SK

available

3015682

GLAXOSMITHKLINE SLOVAKIA S.R.O. GLAXO WELLCOME FARMACÊUTICA, LDA

available

3015781

GLAXO WELLCOME FARMACÊUTICA, LDA

PT

available

16808

GLAXO GROUP LIMITED

CY

available

16809

GLAXO GROUP LIMITED

CY

List of nationally authorised medicinal products EMA/846273/2017

PT

Page 42/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

GLAXOSMITHKLINE SLOVAKIA S.R.O. GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LIMITED GLAXO WELLCOME UK LTD TRADING AS GLAXOSMITHKLINE UK ALLEN FARMACÉUTICA, S.A

SK

number Flixotide Diskus 250 µg inhalacny prasok Cutivate 0,05 mg/g unguent Cutivate 0,5 mg/g crema

not available

14/0144/15-S

not available

9564/2016/01

not available

9565/2016/01

Flixonase Aqueous Nasal Spray

not available

PL 10949/0036

INALACOR 50 mg, Suspensión para inhalación en envase a presión Flutide  fo Dosier-Aerosol Druckgasinhalation, Suspension Fluticasonpropionat „Allen“ Diskus junior 100 Mikrogramm - Pulver zur Trockeninhalation Fluticasonpropionat „Allen“ Diskus standard 250 Mikrogramm Pulver zur Trockeninhalation Fluticasonpropionat „Allen“ Diskus forte 500 Mikrogramm - Pulver zur Trockeninhalation Fluticasonpropionat „Allen“ junior 50 Mikrogramm Dosieraerosol

not available

60.686

not available

39639.03.00

GLAXOSMITHKLINE GMBH & CO. KG

DE

not available

135048

ALLEN PHARMAZEUTIKA GESELLSCHAFT M.B.H.

AT

not available

135047

ALLEN PHARMAZEUTIKA GESELLSCHAFT M.B.H.

AT

not available

135050

ALLEN PHARMAZEUTIKA GESELLSCHAFT M.B.H.

AT

not available

135045

ALLEN PHARMAZEUTIKA GESELLSCHAFT M.B.H.

AT

List of nationally authorised medicinal products EMA/846273/2017

RO RO UK ES

Page 43/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Fluticasonpropionat „Allen“ standard 125 Mikrogramm – Dosieraerosol Fluticasonpropionat „Allen“ forte 250 Mikrogramm Dosieraerosol Fluticasone Cipla 125 mikrogram/dos inhalationsspray, suspension Flixotide Diskus 100 mikrograma Flixotide Diskus 250 mikrograma Flixotide Inhaler 50 mikrograma/dozi, stlaceni inhalat, suspenzija Flixotide Inhaler 250 mikrograma/dozi, stlaceni inhalat, suspenzija Otri-Allergie® Nasenspray Fluticason 0,05 mg Fluticasonpropionat/Sprü hstoß Nasenspray, Suspension Für Erwachsene Fluticasonpropionaat 50 microgram/dosis Focus, neusspray, suspensie

not available

135033

ALLEN PHARMAZEUTIKA GESELLSCHAFT M.B.H.

AT

not available

135044

ALLEN PHARMAZEUTIKA GESELLSCHAFT M.B.H.

AT

SE/H/1284/001

48019

CIPLA (EU) LIMITED

SE

not available

HR-H-981610940

GLAXOSMITHKLINE D.O.O.

HR

not available

HR-H-768919972

GLAXOSMITHKLINE D.O.O.

HR

not available

UP/I-530-09/12-02/401

GLAXOSMITHKLINE D.O.O.

HR

not available

UP/I-530-09/12-02/403

GLAXOSMITHKLINE D.O.O.

HR

not available

23248.00.00

GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH & CO. KG

DE

not available

RVG 108927

FOCUS CARE PHARMACEUTICALS B.V.

NL

List of nationally authorised medicinal products EMA/846273/2017

Page 44/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Aerosona 125 microgramos/inhalación suspensión para inhalación en envase a presión Aerosona 250 microgramos/inhalación suspensión para inhalación en envase a presión Fluticasone Cipla 125 mikrogram/dos inhalationsspray, suspension Fluticasone Cipla 250 mikrogram/dos inhalationsspray, suspension Fluticrem 0,5 mg/g Creme Fluticrem 0,5 mg/g crema Fluticrem 0,5 mg/g crème Fluticrem 0,05% crema Fluticrem 0,5 mg/g Creme Fluticrem 0,5 mg/g crema Fluticrem 0,5 mg/g crème Fluticrem 0,05% crema Arquist 125 microgram per actuation pressurised inhalation, suspension

SE/H/1284/001

78162

SANDOZ FARMACÉUTICA, S.A.

ES

SE/H/1284/002

78163

SANDOZ FARMACÉUTICA, S.A.

ES

SE/H/1284/001

48019

CIPLA (EU) LIMITED

SE

SE/H/1284/002

48020

CIPLA (EU) LIMITED

SE

NL/H/1296/001

5236203

IFC SKINCARE PORTUGAL

PT

NL/H/1296/001

72.017

ES

NL/H/1296/001

RVG 102091

NL/H/1296/001 NL/H/1296/001

039738012 5236203

INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. DIFA COOPER S.P.A. IFC SKINCARE PORTUGAL

NL/H/1296/001

72.017

ES

NL/H/1296/001

RVG 102091

NL/H/1296/001 SE/H/1580/001

039738012 53659

INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. INDUSTRIAL FARMACEUTICA CANTABRIA, S.A. DIFA COOPER S.P.A. CIPLA (EU) LIMITED

List of nationally authorised medicinal products EMA/846273/2017

NL IT PT

NL IT SE

Page 45/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Arquist 250 microgram per actuation pressurised inhalation, suspension Aerosona 125 microgramos/inhalación suspensión para inhalación en envase a presión Aerosona 250 microgramos/inhalación suspensión para inhalación en envase a presión Fluticasone Cipla 125 mikrogram/dos inhalationsspray, suspension Fluticasone Cipla 250 mikrogram/dos inhalationsspray, suspension Flunutrac 0,05% crema CORTIFIL 0,5 mg/g crème CORTIFIL 0.05% cream

SE/H/1580/002

53660

CIPLA (EU) LIMITED

SE

SE/H/1284/001

78162

SANDOZ FARMACÉUTICA, S.A.

ES

SE/H/1284/002

78163

SANDOZ FARMACÉUTICA, S.A.

ES

SE/H/1284/001

48019

CIPLA (EU) LIMITED

SE

SE/H/1284/002

48020

CIPLA (EU) LIMITED

SE

NL/H/1295/001 NL/H/1295/001

040943019 RVG 102106

IT NL

NL/H/1295/001

PL17156/0002

Flunutrac 0,5 mg/g crema Flunutra 0,5 mg/g creme Reviflut Axahaler 125 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 125 mikrogramm inhalációs por kemény kapszulában

NL/H/1295/001

72.411

ISDIN S.R.L. LABORATORIOS SALVAT, S.A. LABORATORIOS SALVAT, S.A. ISDIN, S.A.

NL/H/1295/001 not available

5236179 OGYI-T-22448/02

ISDIN LDA SAGER PHARMA KFT.

PT HU

not available

OGYI-T-22448/03

SAGER PHARMA KFT.

HU

List of nationally authorised medicinal products EMA/846273/2017

UK ES

Page 46/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Reviflut Axahaler 125 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 125 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 125 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 125 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 125 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 125 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 250 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 250 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 250 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 250 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 250 mikrogramm inhalációs por kemény kapszulában

not available

OGYI-T-22448/04

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/05

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/06

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/07

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/08

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/09

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/11

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/12

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/13

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/14

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/15

SAGER PHARMA KFT.

HU

List of nationally authorised medicinal products EMA/846273/2017

Page 47/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number Reviflut Axahaler 250 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 250 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 250 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 125 mikrogramm inhalációs por kemény kapszulában Reviflut Axahaler 250 mikrogramm inhalációs por kemény kapszulában PAVETOD “500 mcg/2 ml sospensione da nebulizzare” PAVETOD “500 mcg/2 ml sospensione da nebulizzare” PAVETOD “2 mg/2 ml sospensione da nebulizzare” PAVETOD “2 mg/2 ml sospensione da nebulizzare” FLUGENIX “500 mcg/2 ml sospensione da nebulizzare” FLUGENIX “500 mcg/2 ml sospensione da nebulizzare”

not available

OGYI-T-22448/16

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/17

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/18

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/01

SAGER PHARMA KFT.

HU

not available

OGYI-T-22448/10

SAGER PHARMA KFT.

HU

not available

043084019

GENETIC SPA

IT

not available

043084021

GENETIC SPA

IT

not available

043084033

GENETIC SPA

IT

not available

043084045

GENETIC SPA

IT

not available

043088018

GENETIC SPA

IT

not available

043088020

GENETIC SPA

IT

List of nationally authorised medicinal products EMA/846273/2017

Page 48/49

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number FLUGENIX “2 mg/2 ml sospensione da nebulizzare” FLUGENIX “2 mg/2 ml sospensione da nebulizzare” Fluticasonpropionaat Sandoz 50, neusspray, suspensie 50 microgram/dosis Fluticasonpropionaat 125 microgram/dosis Vincion, aërosol, suspensie Fluticasonpropionaat 250 microgram/dosis Vincion, aërosol, suspensie Fluticasonpropionaat 50 Basic Pharma, neusspray, suspensie 50 microgram/dosis Fluticasonpropionaat 50 microgram/dosis Basic Pharma, neusspray, suspensie

not available

043088032

GENETIC SPA

IT

not available

043088044

GENETIC SPA

IT

RVG 32157

RVG 32157

SANDOZ B.V.

NL

not available

RVG 116004

VINCION BV

NL

not available

RVG 116005

VINCION BV

NL

not available

RVG 101118

Basic Pharma Manufacturing

NL

not available

RVG 108852

Basic Pharma Manufacturing

NL

List of nationally authorised medicinal products EMA/846273/2017

Page 49/49

Fluticasone propionate - European Medicines Agency - Europa EU

Nov 8, 2017 - (UK) TRADING LIMITED. EE. Fluticasone propionate. 50 micrograms/actuation nasal spray, suspension. UK/H/5780/001. PA 678/118/1. GLAXOSMITHKLINE. CONSUMER HEALTHCARE. (IRELAND) LTD. IE. Flixonase 50 mikrogrami/ izsmidzinājumā deguna aerosols, suspensija. UK/H/5780/001. 15-0221.

479KB Sizes 88 Downloads 243 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...